帕维拉治疗 PVLA
$175.92 +$19.07 (+12.16%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $175.92 0.00%
开盘$158.01
昨收$156.85
当日区间$156.54 – $176.94
成交量502.0K
市值$2.57B
市盈率（TTM）–
股息率–
PVLA 相关新闻
匹配 Palvella Therapeutics 或代码 PVLA 的头条新闻，按最新排序。
- Chardan Capital Initiates Palvella Therapeutics(PVLA.US) With Buy Rating, Announces Target Price $240
- Palvella Therapeutics(PVLA.US) Director Sells US$4.17 Million in Common Stock
- Form 144 | Palvella Therapeutics(PVLA.US) Director Proposes to Sell 4.14 Million in Common Stocks
- Mizuho Securities Maintains Palvella Therapeutics(PVLA.US) With Buy Rating, Maintains Target Price $240
- H.C. Wainwright Maintains Palvella Therapeutics(PVLA.US) With Buy Rating, Maintains Target Price $270
- Truist Financial Maintains Palvella Therapeutics(PVLA.US) With Buy Rating, Announces Target Price $207
- A Quick Look at Today's Ratings for Palvella Therapeutics(PVLA.US), With a Forecast Between $207 to $267
- Oppenheimer Maintains Palvella Therapeutics(PVLA.US) With Buy Rating, Maintains Target Price $210
- LifeSci Capital Maintains Palvella Therapeutics(PVLA.US) With Buy Rating, Maintains Target Price $225
- BTIG Maintains Palvella Therapeutics(PVLA.US) With Buy Rating, Maintains Target Price $215
- TD Cowen Maintains Palvella Therapeutics(PVLA.US) With Buy Rating, Raises Target Price to $267 正面
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Concentra Group Holdings Parent, Inc. (CON) and Palvella Therapeutics (PVLA)
- CCORF Maintains Palvella Therapeutics(PVLA.US) With Buy Rating, Maintains Target Price $227
- Stifel Maintains Palvella Therapeutics(PVLA.US) With Buy Rating, Maintains Target Price $250
- Craig-Hallum Maintains Palvella Therapeutics(PVLA.US) With Buy Rating, Announces Target Price $205
暂无评论——快来第一个聊聊 PVLA。
登录后参与讨论。